Stem Cell Space in Research and Regenerative Medicine

Enal Razvi, Biotechnology Analyst, Select Biosc

To purchase a DVD containing all of the presentations featured at Stem Cells World Congress 2008 please go to the Select Biosciences website.

Launch presentation

About the speaker

Dr. Enal Razvi is currently a biotechnology business development consultant based in the San Francisco Bay Area. In this capacity, Dr. Razvi analyzes a number of different market spaces inbiotechnology and assists companies in market analysis, business development, and commercialization operations. Previously, Dr. Razvi served as Vice President of Business Development at DiscoveRx Corporation in Fremont, California. Before DiscoveRx, at LJL BioSystems (Sunnyvale, CA), Dr. Razvi served as Senior Director of Business Development and played a major role in developing LJL BioSystems' SNP genotyping business. Subsequent to the acquisition of LJL BioSystems by Molecular Devices Corporation, Dr. Razvi ran Molecular Devices' Genomics business. Prior to LJL, while at Frost & Sullivan, Dr. Razvi served as Director of their Drug Discovery Consulting business. Dr. Razvi holds a doctorate in biomedical sciences, and completed post-doctoral work at The Rockefeller University in New York and at Harvard Medical School.

Abstract

The focus of this presentation is to present snapshots from Select Biosciences’ industry tracking of the global stem cells marketplace. Detailed analysis of this market is found in Select Biosciences recently-published Stem Cells in Regenerative Medicine 2008 Market Report. As part of our continuing industry coverage, Select Biosciences has been collecting data concerning the research activities of stem cell researchers worldwide. We have, for instance, mapped the types of vendors supplying products to the research community. We have segmented the market by the type of stem cells studied and utilized in research activities. Select Biosciences has also analyzed the competitive landscape in terms of types of companies, their research focus, and their offering (research products or regenerative medicine)—these topics are discussed in this presentation. Select Biosciences has also tracked the increasing usage of stem cells in drug discovery/development and toxicity screening—our market surveys illustrate the penetrance of these activities in the marketplace currently. Select Biosciences is also tracking the worldwide stem cells-focused clinical trials and illustrates in this presentation the type of trials, their focal area, and the global breakout of these trials.

Launch presentation